Degen, Martin

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2022 | 2021 | 2020 | 2019 | 2018 | 2016


Parisi, Ludovica; Mockenhaupt, Carolin; Rihs, Silvia; Mansour, Farah; Katsaros, Christos; Degen, Martin (2022). Consistent downregulation of the cleft lip/palate-associated genes IRF6 and GRHL3 in carcinomas. Frontiers in oncology, 12(1023072), p. 1023072. Frontiers Research Foundation 10.3389/fonc.2022.1023072

Parisi, Ludovica; Rihs, Silvia; La Scala, Giorgio C; Schnyder, Isabelle; Katsaros, Christos; Degen, Martin (2022). Discovery and characterization of heterogeneous and multipotent fibroblast populations isolated from excised cleft lip tissue. Stem cell research & therapy, 13(1), p. 469. BioMed Central 10.1186/s13287-022-03154-x

Tucker, Richard P; Degen, Martin (2022). Revisiting the Tenascins: Exploitable as Cancer Targets? Frontiers in oncology, 12, p. 908247. Frontiers Research Foundation 10.3389/fonc.2022.908247


Girousi, Eleftheria; Mürner, Lukas; Parisi, Ludovica; Rihs, Silvia; von Gunten, Stephan; Katsaros, Christos; Degen, Martin (2021). Lack of IRF6 Disrupts Human Epithelial Homeostasis by Altering Colony Morphology, Migration Pattern, and Differentiation Potential of Keratinocytes. Frontiers in cell and developmental biology, 9(718066), p. 718066. Frontiers 10.3389/fcell.2021.718066

Degen, Martin; Scherberich, Arnaud; Tucker, Richard P (2021). Tenascin-W: Discovery, Evolution, and Future Prospects. Frontiers in immunology, 11(623305), p. 623305. Frontiers Research Foundation 10.3389/fimmu.2020.623305

Hendaoui, Ismaïl; Lahmar, Ahlem; Campo, Luca; Mebarki, Sihem; Bichet, Sandrine; Hess, Daniel; Degen, Martin; Kchir, Nidhameddine; Charrada-Ben Farhat, Leila; Hefaiedh, Rania; Ruiz, Christian; Terracciano, Luigi M; Tucker, Richard P; Hendaoui, Lotfi; Chiquet-Ehrismann, Ruth (2021). Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers. Frontiers in immunology, 11, p. 630139. Frontiers Research Foundation 10.3389/fimmu.2020.630139

Parisi, Ludovica; Knapp, Patrick O.; Girousi, Eleftheria; Rihs, Silvia; La Scala, Giorgio C.; Schnyder, Isabelle; Stähli, Alexandra; Sculean, Anton; Bosshardt, Dieter; Katsaros, Christos; Degen, Martin (2021). A Living Cell Repository of the Cranio-/Orofacial Region to Advance Research and Promote Personalized Medicine. Frontiers in cell and developmental biology, 9, p. 682944. Frontiers 10.3389/fcell.2021.682944


Selnø, Anette Teo Hansen; Schlichtner, Stephanie; Yasinska, Inna M.; Sakhnevych, Svetlana S.; Fiedler, Walter; Wellbrock, Jasmin; Klenova, Elena; Pavlova, Ludmila; Gibbs, Bernhard F.; Degen, Martin; Schnyder, Isabelle; Aliu, Nijas; Berger, Steffen M.; Fasler-Kan, Elizaveta; Sumbayev, Vadim V. (2020). Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells. Aging, 12(23), pp. 23478-23496. Impact Journals 10.18632/aging.202343

Degen, Martin; Girousi, Eleftheria; Feldmann, Julia; Parisi, Ludovica; La Scala, Giorgio C.; Schnyder, Isabelle; Schaller, André; Katsaros, Christos (2020). A Novel Van der Woude Syndrome-Causing IRF6 Variant Is Subject to Incomplete Non-sense-Mediated mRNA Decay Affecting the Phenotype of Keratinocytes. Frontiers in cell and developmental biology, 8, p. 583115. Frontiers 10.3389/fcell.2020.583115


Tucker, Richard P; Degen, Martin (2019). The Expression and Possible Functions of Tenascin-W During Development and Disease. Frontiers in cell and developmental biology, 7(53), p. 53. Frontiers 10.3389/fcell.2019.00053


Degen, Martin; Wiederkehr, Astrid; La Scala, Giorgio C.; Carmann, Christina; Schnyder, Isabelle; Katsaros, Christos (2018). Keratinocytes Isolated From Individual Cleft Lip/Palate Patients Display Variations in Their Differentiation Potential in vitro. Frontiers in physiology, 9, p. 1703. Frontiers Research Foundation 10.3389/fphys.2018.01703


Ferralli, Jacqueline; Chiquet-Ehrismann, Ruth; Degen, Martin (2016). KLF4α stimulates breast cancer cell proliferation by acting as a KLF4 antagonist. OncoTarget, 7(29), pp. 45608-45621. Impact Journals LLC 10.18632/oncotarget.10058

Provide Feedback